Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management

Clinical trial NCT05362760 · RECRUITING

Trial details

NCT number

NCT05362760

Sponsor

Prof. Wolfgang Janni

Status

RECRUITING

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2022-04-27

Primary completion

2029-04-01

Enrollment

300

View on ClinicalTrials.gov